BLADE AIR MOBILITY INC (BLDE) Stock Fundamental Analysis

NASDAQ:BLDE • US0926671043

4.73 USD
+0.15 (+3.28%)
At close: Aug 28, 2025
4.75 USD
+0.02 (+0.42%)
After Hours: 8/28/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

BLDE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 22 industry peers in the Passenger Airlines industry. BLDE has a great financial health rating, but its profitability evaluates not so good. BLDE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • BLDE had negative earnings in the past year.
  • BLDE had a positive operating cash flow in the past year.
  • BLDE had negative earnings in each of the past 5 years.
  • In the past 5 years BLDE always reported negative operating cash flow.
BLDE Yearly Net Income VS EBIT VS OCF VS FCFBLDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M -50M

1.2 Ratios

  • The Return On Assets of BLDE (-7.36%) is worse than 65.22% of its industry peers.
  • BLDE's Return On Equity of -8.51% is in line compared to the rest of the industry. BLDE outperforms 56.52% of its industry peers.
Industry RankSector Rank
ROA -7.36%
ROE -8.51%
ROIC N/A
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
BLDE Yearly ROA, ROE, ROICBLDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • BLDE's Gross Margin of 25.01% is on the low side compared to the rest of the industry. BLDE is outperformed by 69.57% of its industry peers.
  • BLDE's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BLDE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
BLDE Yearly Profit, Operating, Gross MarginsBLDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • BLDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BLDE has been increased compared to 1 year ago.
  • Compared to 5 years ago, BLDE has more shares outstanding
  • BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLDE Yearly Shares OutstandingBLDE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
BLDE Yearly Total Debt VS Total AssetsBLDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • BLDE has an Altman-Z score of 6.88. This indicates that BLDE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.88, BLDE belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
  • There is no outstanding debt for BLDE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.88
ROIC/WACCN/A
WACC9.44%
BLDE Yearly LT Debt VS Equity VS FCFBLDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • BLDE has a Current Ratio of 5.95. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.95, BLDE belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
  • BLDE has a Quick Ratio of 5.95. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 5.95, BLDE belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.95
Quick Ratio 5.95
BLDE Yearly Current Assets VS Current LiabilitesBLDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • BLDE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.12%, which is quite impressive.
  • Looking at the last year, BLDE shows a small growth in Revenue. The Revenue has grown by 6.70% in the last year.
  • Measured over the past years, BLDE shows a very strong growth in Revenue. The Revenue has been growing by 70.13% on average per year.
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%

3.2 Future

  • BLDE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.77% yearly.
  • Based on estimates for the next years, BLDE will show a very strong growth in Revenue. The Revenue will grow by 26.27% on average per year.
EPS Next Y64.16%
EPS Next 2Y27.05%
EPS Next 3Y24.23%
EPS Next 5Y41.77%
Revenue Next Year7.5%
Revenue Next 2Y7.32%
Revenue Next 3Y7.57%
Revenue Next 5Y26.27%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLDE Yearly Revenue VS EstimatesBLDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
BLDE Yearly EPS VS EstimatesBLDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BLDE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDE Price Earnings VS Forward Price EarningsBLDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDE Per share dataBLDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • BLDE's earnings are expected to grow with 24.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.05%
EPS Next 3Y24.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BLDE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BLADE AIR MOBILITY INC

NASDAQ:BLDE (8/28/2025, 8:00:02 PM)

After market: 4.75 +0.02 (+0.42%)

4.73

+0.15 (+3.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05
Earnings (Next)11-10
Inst OwnersN/A
Inst Owner Change1.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap386.44M
Revenue(TTM)254.34M
Net Income(TTM)-18.98M
Analysts85.45
Price Target7.91 (67.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.79%
Min EPS beat(2)-11.41%
Max EPS beat(2)64.99%
EPS beat(4)2
Avg EPS beat(4)16.68%
Min EPS beat(4)-24.95%
Max EPS beat(4)64.99%
EPS beat(8)4
Avg EPS beat(8)-21.68%
EPS beat(12)6
Avg EPS beat(12)-13.54%
EPS beat(16)9
Avg EPS beat(16)-24.3%
Revenue beat(2)2
Avg Revenue beat(2)8.01%
Min Revenue beat(2)7.7%
Max Revenue beat(2)8.32%
Revenue beat(4)3
Avg Revenue beat(4)4.72%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)8.32%
Revenue beat(8)6
Avg Revenue beat(8)3.41%
Revenue beat(12)10
Avg Revenue beat(12)5.68%
Revenue beat(16)14
Avg Revenue beat(16)11.59%
PT rev (1m)7.64%
PT rev (3m)7.64%
EPS NQ rev (1m)-79.16%
EPS NQ rev (3m)-80.94%
EPS NY rev (1m)-16.07%
EPS NY rev (3m)4.41%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)2.03%
Revenue NY rev (3m)2.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.52
P/FCF N/A
P/OCF 298.87
P/B 1.73
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.02
OCFY0.33%
SpS3.11
BVpS2.73
TBVpS2.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.36%
ROE -8.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.01%
FCFM N/A
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 331.71%
Cap/Sales 8.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.95
Quick Ratio 5.95
Altman-Z 6.88
F-Score6
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)198.6%
Cap/Depr(5y)143.5%
Cap/Sales(3y)4.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y64.16%
EPS Next 2Y27.05%
EPS Next 3Y24.23%
EPS Next 5Y41.77%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%
Revenue Next Year7.5%
Revenue Next 2Y7.32%
Revenue Next 3Y7.57%
Revenue Next 5Y26.27%
EBIT growth 1Y62.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.57%
EBIT Next 3Y41.77%
EBIT Next 5Y38.84%
FCF growth 1Y53.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.19%
OCF growth 3YN/A
OCF growth 5YN/A

BLADE AIR MOBILITY INC / BLDE FAQ

Can you provide the ChartMill fundamental rating for BLADE AIR MOBILITY INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDE.


What is the valuation status of BLADE AIR MOBILITY INC (BLDE) stock?

ChartMill assigns a valuation rating of 1 / 10 to BLADE AIR MOBILITY INC (BLDE). This can be considered as Overvalued.


Can you provide the profitability details for BLADE AIR MOBILITY INC?

BLADE AIR MOBILITY INC (BLDE) has a profitability rating of 1 / 10.


Can you provide the financial health for BLDE stock?

The financial health rating of BLADE AIR MOBILITY INC (BLDE) is 8 / 10.